George Rathmann Dies

George Rathmann, Amgen's founding chief executive, has died, reports The New York Times. He was 84. Rathmann led Amgen in the 1980s while it developed what the Times calls "two of the most successful drugs in history" — Epogen and Neupogen. "He was the one who created the company, without any doubt," says Lowell Sears, a former chief financial officer at Amgen.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.